Categories: Clinical TrialNews

ClinCapture Unveils New eTMF and Enhanced Subject Audit Log Export Features

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

LAS VEGAS, March 18, 2025 /PRNewswire/ — ClinCapture, a leader in clinical trial management solutions, is excited to announce the launch of two groundbreaking feature enhancements designed to streamline study documentation and audit processes for clinical research organizations worldwide.

Revolutionizing Document Management with eTMF Capabilities
The newly integrated eTMF (electronic Trial Master File) functionality offers robust tools to:

  • Store Study Documents: Safely archive all study-related documents in a centralized digital repository.
  • Create Study Folders: Organize documents efficiently by creating dedicated folders for each study.
  • Store Site Documents: Maintain secure storage for documents specific to individual study sites.
  • Version Control: Track document revisions and maintain historical records effortlessly.
  • Manage Study/Site Document Permissions: Customize user access to ensure that sensitive information is shared only with authorized personnel.

“Our new eTMF capabilities are designed to provide researchers with a seamless and secure document management experience,” said Scott Weidley, CEO at ClinCapture. “By centralizing study and site documentation and offering granular permission controls, we empower our users to manage their documents exactly their way.”

Streamlining Audit Processes with Enhanced Subject Audit Log Export
In addition to powerful document management, ClinCapture now introduces the Enhanced Subject Audit Log Export feature, allowing users to:

  • Export All Subjects at a Site: Quickly generate comprehensive audit logs for every subject associated with a study site.
  • Filter Exports for Key Insights: All data in one csv file that will allow users to see trends.
  • Save Time and Increase Efficiency: Eliminate the need to download logs individually for each subject, providing a more efficient review process.

“The Enhanced Subject Audit Log Export feature is a game-changer for our users,” said Amanda McLean, VP of Sales and Customer Enablement. “By simplifying the audit process and clinical research teams can now focus more on analysis and decision-making rather than administrative tasks.”

Key Benefits for Users

  • Centralized Documentation: Keep all study and site documents in one accessible location.
  • Customized Organization: Tailor the document management system to meet the unique needs of each study.
  • Enhanced Permission Control: Maintain strict control over document access, ensuring data security.
  • Time-Saving Exports: Generate comprehensive audit logs quickly, improving overall operational efficiency.
  • Insightful Data Filtering: Identify trends and patterns across various study parameters to enhance study oversight and reporting.

ClinCapture’s commitment to innovation in clinical research is underscored by these new feature releases designed to support efficient study management and robust data analysis. For more information about these new features or to schedule a product demo, please visit ClinCapture.com or contact our press team at jacob.roach@clincapture.com.

About ClinCapture
ClinCapture is a leading provider of clinical trial management solutions, dedicated to empowering research teams with secure, innovative, and effective tools. With a focus on enhancing productivity and ensuring compliance, ClinCapture continues to set the standard in clinical research technology.

View original content to download multimedia:https://www.prnewswire.com/news-releases/clincapture-unveils-new-etmf-and-enhanced-subject-audit-log-export-features-302403878.html

SOURCE ClinCapture, Inc.

Staff

Recent Posts

Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update

- Regulatory alignment with FDA confirmed, clearing path to pivotal U.S. clinical trial -- 150-page…

5 hours ago

NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or the “Company”), a medical technology company specializing…

10 hours ago

Movano Health’s Board of Directors Initiates Process to Maximize Shareholder Value

PLEASANTON, Calif., May 16, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology,…

10 hours ago

Eastern Michigan University unveils Way Forward@EMU, empowering youth health leaders with $1M Toyota grant

YPSILANTI, Mich., May 16, 2025 /PRNewswire/ -- Eastern Michigan University is revolutionizing health education for…

10 hours ago

New Healthcare AI Models Could Reshape Everything From Burnout to Diagnostics

Equity Insider News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 16, 2025…

10 hours ago